Skip to content

American Radiosurgery

How stereotactic radiosurgery treats the brain without a cut, what it can and cannot do, and what the day in the frame is actually like.
Gamma Knife radiosurgery, from the first scan to the years of follow-up.

Questions to Ask Before Gamma Knife: A Consultation Checklist

By Ruth Alderman  |  Medically reviewed by Mr Edward Halloran, FRCS (SN)

Published May 29, 2026 · Last reviewed June 15, 2026 · 7 min read

Key takeaways

  • Ask which platform and technique you will have (frame-based single session or mask-based hypofractionation), because that decides the day and whether pins are involved.
  • Ask for the numbers that apply to your target specifically: the margin dose, the expected control rate, and the main risks for your condition, not a general figure.
  • Ask who plans the dose and who reads your follow-up scans; the plan is made by a team (a neurosurgeon, a radiation oncologist and a physicist) and the result unfolds over months to years.
  • Ask what the alternatives are, including surgery and watching and waiting, and why radiosurgery is being recommended over them for you.
  • Write your questions down and take someone with you; the appointment holds more than you will remember once the word tumour has been said.

The five questions that matter most before Gamma Knife are: which platform and technique you will have, what margin dose is planned for your target, the expected control rate and main risks for your specific condition, who reads your follow-up scans, and what the alternatives are and why radiosurgery is being recommended for you. Everything else is detail around those five. Gamma Knife is a form of stereotactic radiosurgery, a non-invasive treatment in which many weak beams of cobalt-60 gamma radiation converge on a target in the brain, so the questions worth asking are less about the machine and more about how it will be aimed at you1.

When my acoustic neuroma was found I went into the consultation with a head full of fear and one vague question (“is it serious?”), and I came out having absorbed almost nothing. The second time I went back with a written list, and it was a completely different appointment. This is the list I wish I had taken the first time. For the treatment itself, see the pillar on Gamma Knife radiosurgery; if you are still working out whether it is even an option for you, start with am I a candidate for Gamma Knife.

Which platform and technique will I have?

Ask whether you will have frame-based radiosurgery in a single session or a mask-based technique split over a few sessions, because that single answer shapes your whole day. Traditionally Gamma Knife uses a rigid metal frame pinned to the skull with four pins after four injections of local anaesthetic; you feel pressure rather than pain. Modern Icon-generation units can instead use a custom thermoplastic mask with cone-beam CT, which allows the dose to be divided over a few sessions, called hypofractionation2.

It is fair to ask which Elekta model they use (current ones are the Perfexion, the Leksell Icon and the Gamma Knife Esprit) and how many cobalt-60 beams it delivers (current units use 192, older ones used 201). But the practical thing you are really asking is: pins or a mask, and one session or a few. That decides whether you should expect a whole day in one go or several shorter visits. For the difference in plain terms, see frame-based versus frameless radiosurgery and what the frame feels like.

What dose will I get, and why?

Ask for the margin dose planned for your target, because the dose is chosen for your specific condition and is the number that drives both the chance of control and the risk. The margin dose is the dose delivered to the edge of the target, and it varies a lot by condition. As a guide, it is commonly about 12 to 13 Gy for an acoustic neuroma, 12 to 16 Gy for a benign meningioma, 18 to 25 Gy for an AVM, and around 80 Gy to the nerve root for trigeminal neuralgia1.

You will not need to check the physics, but asking the question tells you the plan is being tailored to you rather than pulled from a template. It also opens the door to the follow-up worth asking: what dose is nearby healthy tissue expected to receive, and what is done to keep it low. The dose is planned by a team (a neurosurgeon, a radiation oncologist and a physicist) while you wait, over one to several hours. For more, see Gamma Knife planning and dose.

What are my chances of it working?

Ask for the expected control rate for your condition and size, not a general figure, because outcomes vary widely by condition, size, dose and follow-up length. A single number quoted without those qualifiers is not much use. To give a sense of the range: 5-year tumour control for an acoustic neuroma is roughly 90 to 99%; for a benign (grade I) meningioma it is roughly 85 to 100%; 1-year local control for brain metastases is roughly 70 to 90% and strongly dose-dependent; and AVM closure is roughly 65 to 90% over a latency of 2 to 3 years3.

The honest follow-up questions are the useful ones: what does control mean for me, and what happens if the target keeps growing? Control means the target stops growing, which is not the same as it disappearing. Radiosurgery works gradually, and the target usually stays visible on scans; benign tumours change slowly over 1 to 3 years. Ask what the plan would be if a follow-up scan showed growth, whether that is repeat radiosurgery, surgery, or something else. See Gamma Knife results and follow-up and, if you are weighing it against an operation, Gamma Knife versus surgery.

What are the risks for my specific target?

Ask about the risks for your particular target, because general figures hide the ones that actually apply to you. The most important delayed effect across the board is radiation necrosis, roughly 5 to 25% depending on the size of the target (particularly over 20 mm) and the dose, and often manageable, for example with steroids. Early effects are usually mild and temporary: fatigue, headache, and, for frame-based treatment, brief pin-site soreness2.

Then narrow it to your target. For a skull-base lesion such as an acoustic neuroma, ask about cranial-nerve effects and hearing; hearing preservation varies widely, roughly 40 to 80%, and declines over the years. For a pituitary or skull-base target, ask about the chance of hypopituitarism, which is highly variable and reported anywhere from 0 to 70% by size, location and follow-up. The reassuring one to name is a second tumour caused by the radiation: real, but on the order of well under 1% over many years. I found that asking about my own tumour by name, rather than “the risks” in the abstract, got me far more honest answers. See Gamma Knife risks and side effects and radiation necrosis, what I learned.

Who reads my follow-up scans, and when?

Ask who reviews your follow-up scans and on what schedule, because the treatment is only the start and the result shows up on imaging over months to years, not on the day. A typical schedule is an office visit at about a month, then MRI scans commonly at 3, 6 and 12 months, moving to every 4 to 6 months for longer-term follow-up, though this varies by centre2.

The questions that made the biggest difference to me were the boring-sounding ones: who actually looks at each scan, how will I be told the result, and who do I ring if something changes between scans? Knowing the answers took a lot of the dread out of the waiting, which is real and has a name. If the gap between scans is the hard part for you, as it was for me, see radiosurgery and scanxiety and Gamma Knife recovery.

What are my alternatives, and why this?

Ask what the alternatives are and why radiosurgery is being recommended over them, because the choice between radiosurgery, surgery and watching and waiting is a genuine decision made by a team who can see your imaging. Single-session radiosurgery typically suits targets around 3 to 3.5 cm or smaller (about 10 to 15 cc in volume); larger ones are usually treated with surgery or with the dose staged over several sessions. Open surgery may be preferred when a large tumour needs rapid relief of pressure or a tissue diagnosis4.

I had assumed radiosurgery was automatically the gentler and therefore better choice; in fact my team had weighed it against watching and waiting and against surgery before they recommended it, and being told why was more reassuring than the recommendation on its own. So ask plainly: what would happen if I did nothing for now, what would surgery involve, and what tipped the decision towards radiosurgery for me. See watch and wait versus Gamma Knife and, if machines are being compared, Gamma Knife versus CyberKnife.

How to get the most out of the appointment

Write your questions down before you go, take someone with you, and ask how to send anything you forget, because you will not remember everything once the word tumour has been said. This is not a clinical fact so much as hard-won experience: the appointment holds far more information than fear will let you keep hold of. A second person hears what you miss, and a written list means you leave having actually asked what you came to ask.

If you would like a starting point, the practical five are: which platform and technique, what margin dose and why, the expected control and risks for my target, who reads my follow-up scans, and what the alternatives are. For the emotional side of walking into that room, which nobody prepared me for, see the emotional side of a brain-tumour diagnosis and the reassurance piece Gamma Knife myths and facts.

References

  1. Stereotactic Radiosurgery, American Association of Neurological Surgeons.
  2. Gamma Knife Surgery, Cleveland Clinic.
  3. Stereotactic radiotherapy for brain and spinal cord tumours, Cancer Research UK.
  4. Gamma Knife Treatment, Elekta.

Common questions

What should I ask at a Gamma Knife consultation?

Ask five things: which platform and technique you will have (frame-based single session or mask-based hypofractionation), the margin dose planned for your target, the expected control rate and main risks for your specific condition, who reads your follow-up scans and on what schedule, and what the alternatives are (including surgery and watching and waiting) and why radiosurgery is preferred for you.

Should I ask which Gamma Knife model they use?

Yes, it is a fair question. Current Elekta models are the Perfexion, the Leksell Icon and the Gamma Knife Esprit; Icon-generation units can use a thermoplastic mask instead of a pinned frame and can split the dose over a few sessions. Older units used 201 cobalt-60 sources, current ones use 192. The model matters mainly because it decides whether you have pins or a mask and single or few sessions.

What dose questions matter?

Ask for the margin dose planned for your target, because it is chosen for your condition. Common margin doses are about 12 to 13 Gy for an acoustic neuroma, 12 to 16 Gy for a benign meningioma, 18 to 25 Gy for an AVM and around 80 Gy to the nerve root for trigeminal neuralgia. Ask what control that dose is expected to give and what the risk to nearby structures is.

How do I ask about my chances of it working?

Ask for the expected control rate for your condition and size, not a general figure, because outcomes vary widely. As examples: acoustic neuroma 5-year control is roughly 90 to 99%, benign meningioma roughly 85 to 100%, brain metastases 1-year control roughly 70 to 90%, and AVM closure roughly 65 to 90% over 2 to 3 years. Ask what happens if the target keeps growing.

Who reads my follow-up scans after Gamma Knife?

Ask this directly. The treating team plans your care, and follow-up is typically an office visit at about a month, then MRI scans commonly at 3, 6 and 12 months, spacing to every 4 to 6 months later. Ask who reviews each scan, how you will hear the result, and who to contact between scans if something changes.

Should I ask about the risks for my specific target?

Yes. General risk figures hide a lot. The most important delayed effect is radiation necrosis, roughly 5 to 25% depending on size and dose. For skull-base targets, ask about cranial-nerve effects and hearing; for pituitary or skull-base targets, ask about the chance of hypopituitarism, which varies widely. Ask what is done to keep the dose to healthy tissue low.

Is it rude to ask so many questions?

No. A good team expects it and would rather you understood the plan than nodded through it. Bring your questions written down and take someone with you, because it is hard to take in detail after a brain-tumour diagnosis. If you run out of time, ask how to send follow-up questions before the treatment day.

Written by Ruth Alderman. Medically reviewed by Mr Edward Halloran, FRCS (SN).

Our guides are written from personal experience and reviewed by a qualified clinician for accuracy. Read our editorial policy.

More from us

  1. Gamma Knife Radiosurgery: How It Works, What It Treats, Risks and Results
  2. Gamma Knife Risks and Side Effects: Acute and Delayed, Named Honestly
  3. Gamma Knife for Meningioma: Control Rates, and When It Beats Surgery or Watching
  4. The Latency Period After AVM Radiosurgery: The 2 to 3 Year Wait Explained